Approved Pilot and Failed Pivotal Study [Study As­sess­ment]

posted by kumarnaidu – Mumbai, India, 2014-03-18 06:03 (4484 d 00:57 ago) – Posting: # 12642
Views: 20,877

Hi all,
In this case reference drug itself behaving as a variable drug. Also the inrasubject CV was also > 30%. According to me one should go for the replicate design (reference replicate)in pivotal study. Lets take other members opinion.

Kumar Naidu

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
357 visitors (0 registered, 357 guests [including 20 identified bots]).
Forum time: 08:01 CEST (Europe/Vienna)

Don’t compromise yourself.
You are all you’ve got.    Janis Joplin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5